A modified fragment of the C-terminus of human growth hormone (residues 176-191) studied for fat metabolism without the full growth-promoting effects of intact GH.
Mechanism under study
Research associates AOD-9604 with stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis, reportedly without affecting blood glucose or IGF-1 the way intact GH does.
Research-reported dosing
Research references commonly cite ~300 mcg per day. Clinical obesity trials did not achieve approval for that indication.
5 mg vial + 2 mL bacteriostatic water = 2500 mcg/mL.
A 300 mcg dose ≈ 12 units (25 mcg per unit).
Open this mix in the calculator →Dosing figures describe how this compound appears in the research literature and research-community references. They are not a recommendation for human use.
AOD-9604 FAQ
What is AOD-9604?
A modified fragment of the C-terminus of human growth hormone (residues 176-191) studied for fat metabolism without the full growth-promoting effects of intact GH.
What is the half-life of AOD-9604?
Short in circulation.
What is the research-reported dosing for AOD-9604?
Research references commonly cite ~300 mcg per day. Clinical obesity trials did not achieve approval for that indication.
How is AOD-9604 reconstituted?
5 mg vial + 2 mL bacteriostatic water = 2500 mcg/mL.
Is AOD-9604 FDA-approved?
No — AOD-9604 is not FDA-approved and is sold for laboratory research use only.
References
Related peptides
Semaglutide
GLP-1 receptor agonist
A long-acting GLP-1 receptor agonist, FDA-approved for type-2 diabetes and chronic weight management under brand names Ozempic, Wegovy, and Rybelsus. One of the most-studied incretin peptides.
Tesamorelin
Stabilized GHRH analog
A stabilized GHRH analog that is FDA-approved (as Egrifta) to reduce excess visceral adipose tissue in HIV-associated lipodystrophy — one of the few peptides in this index with an approved human indication.
MOTS-c
Mitochondrial-derived peptide
A mitochondrial-derived peptide studied as a metabolic regulator and exercise-mimetic in preclinical models, and of interest in aging and insulin-sensitivity research.